Abstract:Background: Gram-negative bacilli are one of the most common causes of various infections in clinical. The emergence and global spread of multi-drug resistant gram-negative bacilli has become a major challenge in the global public health field. Methods: A total of 51,189 non-repetitive strains of gram-negative bacilli were isolated in clinical settings. The antimicrobial susceptibility testing was conducted by using the automated VITEK 2 compact system and the matched AST susceptibility test card, complemented by the disk diffusion method. The antimicrobial susceptibility results were interpreted by CLSI. Rates of MDR and XDR in Klebsiella pneumoniae , Acinetobacter baumannii , and Pseudomonas aeruginosa were investigated. Used the chi-square test to determine whether the antimicrobial resistance rates of four major gram-negative bacilli isolated from ICU and non-ICU department have statistical differences. Results: Escherichia coli (31.4%), Klebsiella spp. (21.2%), Acinetobacter spp. (13.8%), and P. aeruginosa (11.0%) were the most frequently isolated gram-negative bacilli. Escherichia coli was the top one organism isolated from urinary tract (68.4%), bloodstream (39.9%), body fluid (33.2%), wound and pus (37%), except for respiratory tract (8.8%). Whereas Acinetobacter baumannii and K. pneumoniae were the major isolated organisms from respiratory tract. Acinetobacter baumannii showed high resistance to fluoroquinolones, β-lactam/β-lactamase inhibitor combinations class, ceftazidime, cefepime, imipenem, and meropenem, the resistance rates reached more than 70%. Ceftazidime showed a lower resistance rate to E. coli than ceftriaxone. For E. coli , fluoroquinolones showed a high resistance rate (ciprofloxacin 61.36% and levofloxacin 53.97%), whereas amikacin, carbapenems exhibited a lower resistance rate fluctuating at 2%. Acinetobacter baumannii and K. pneumoniae showed rapid increases in carbapenem resistance whereas E. coli had the lowest resistance rate and remain stable at 2%. Acinetobacter baumannii exhibited the highest rate of MDR and XDR, reaching 60–80 and 45–55%, respectively. Compared to non-ICU departments, the resistance rates of four major gram-negative bacilli in the ICU department were much higher and the differences were statistically significant ( p < 0.05). Conclusion: Amikacin, carbapenems, and piperacillin/tazobactam exhibited relatively high sensitivity, whereas fluoroquinolones showed high resistance rate whether they can be the first-line antimicrobials for empirical treatment of UTI should take more consideration. The gram-negative bacilli in ICU were more resistance than that in non-ICU. These findings are helpful for clinicians using antimicrobials reasonably.

Study on the antibacterial activity of three carbapenems to the strains isolated from ICU

A 10 year surveillance for antimicrobial susceptibility of Escherichia coli and Klebsiella pneumoniae in community- and hospitalassociated intra-abdominal infections in China

In vitro antibacterial activity of three agents of carbapenems

Study on Antibiotics Resistance of Extended-Spectrum Β-Lactamases-producing Escherichia Coil and Klebsiella Pneumoniae in Hangzhou

Investigation of antibacteriocidal activity of domestic meropenem on β-lacta-mases-producing gram negativ bacilli in vitro

Mohnarin Report of 2011: Monitoring of Bcterial Resistance Intensive Care Unit

Study on the resistance to antibiotics of the isolated pathogens of 408 patients with severe infection from intensive care unit

Resistance Surveillance of 400 Gram-negative Bacterial Isolates from Intensive Care Unit with E-test

Surveillance of Antimicrobial Resistance among Gram-Negative Bacilli from Intensive Care Unit

Comparison of antimicrobial activity in vitro of 7 β-lactams against 280 isolates from patients with nosocomial infections

Mohnarin Report of 2010:Monitoring of Bacterial Resistance in Intensive Care Units

The monitor of bacterium infection in ICU

Study on the Antimicrobial Resistance of Pseudomonas aeruginosa and Acinetobacter baumanni Isolated From Patients in ICU

Study on common pathogenic bacteria in ICU and plasmid mediated drug-resistant gene of Acinetobacter baumannii

Surveillance of antimicrobial resistance among clinical isolates from intensive care units in tertiary hospital, 2012

Distribution and antimicrobial resistance of maj or gram-negative bacilli in ICU and non-ICU wards in a grass-roots hospital

Distribution and antimicrobial resistance analysis of gram-negative bacilli isolated from a tertiary hospital in Central China: a 10-year retrospective study from 2012 to 2021

In vitro activities of 16 antimicrobial agents against Gram-negative bacteria from six teaching hospitals in China.

Analysis on 319 strains pathogenic bacteria distribution and antimicrobial drug sensitive rate in ICU

Study on antimicrobial resistence of cefotetan against Extended-spectrum β-lactamase of Escherichia coil and Kleb siella pneumonia

In vitro antibacterial activity of 13 antibiotics against bacteria producing AmpC β-lactamases or AmpC β-lactamases plus ESBLs